TSG-p53® - Model P53N5 Publications

TSG-p53® - Model P53N5 Model Page

Filter publications by application: All Oncology
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Toledo F, et al.
Mouse over for full list
Toledo F, Liu CW, Lee CJ, Wahl GM
(2006) RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analyses. Nucleic Acids Res. 34(13):e92
Pritchard JB, et al.
Mouse over for full list
Pritchard JB, French JE, Davis BJ, Haseman JK
(2003) The role of transgenic mouse models in carcinogen identification. Environ. Health Perspect. 111(4):444-54
Johansson FK, et al.
Mouse over for full list
Johansson FK, Brodd J, Eklöf C, Ferletta M, Hesselager G, Tiger CF, Uhrbom L, Westermark B
(2004) Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc. Natl. Acad. Sci. U.S.A. 101(31):11334-7
Oncology
Horn TL, et al.
Mouse over for full list
Horn TL, Cwik MJ, Morrissey RL, Kapetanovic I, Crowell JA, Booth TD, McCormick DL
(2007) Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice. Food Chem. Toxicol. 45(1):55-63
Oncology
Ferguson DO, et al.
Mouse over for full list
Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, DePinho RA, Alt FW
(2000) The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl. Acad. Sci. U.S.A. 97(12):6630-3
Donehower LA, et al.
Mouse over for full list
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A
(1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356(6366):215-21
Bielas JH, et al.
Mouse over for full list
Bielas JH, Heddle JA
(2003) Elevated mutagenesis and decreased DNA repair at a transgene are associated with proliferation but not apoptosis in p53-deficient cells. Proc. Natl. Acad. Sci. U.S.A. 100(22):12853-8